Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection-Reference-Cited by-同舟云学术

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

Published:2008-12-27 Issue:12 Volume:86 Page:1754-1761
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Everly Matthew J.,Everly Jason J.,Susskind Brian,Brailey Paul,Arend Lois J.,Alloway Rita R.,Roy-Chaudhury Prabir,Govil Amit,Mogilishetty Gautham,Rike Adele H.,Cardi Michael,Wadih George,Tevar Amit,Woodle E Steve

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference29 articles.

1. The effect of desensitization protocols on human splenic B-cell populations in vivo.;Ramos;Am J Transplant,2007

2. Multiple myeloma.;Kyle;N Engl J Med,2004

3. Proteasome inhibition as a novel therapeutic target in human cancer.;Rajkumar;J Clin Oncol,2005

4. On the role of proteasomes in cell biology and proteasome inhibition as a novel frontier in the development of immunosuppressants.;Wu;Am J Transplant,2002

5. A proteasome inhibitor effectively prevents mouse heart allograft rejection.;Luo;Transplantation,2001

Cited by 356 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bortezomib for antibody‐mediated rejection of kidney transplant in youth: Associations with donor‐specific antibody;Pediatric Transplantation;2024-05-29

2. Kidney Transplantation in Multiple Myeloma and Monoclonal Gammopathy of Renal Significance;Seminars in Nephrology;2024-01

3. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024

4. Current Therapies in Kidney Transplant Rejection;Journal of Clinical Medicine;2023-07-27

5. Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates;American Journal of Transplantation;2023-06